Kidney Stone Size and Spontaneous Passage in Females
Stones ≤5 mm have the highest likelihood of spontaneous passage (75-89%), while stones >10 mm rarely pass without intervention and typically require surgical management. 1
Size-Based Passage Rates
The probability of spontaneous stone passage decreases significantly with increasing stone size:
- Stones <5 mm: Pass spontaneously in approximately 75-89% of cases, with distal ureteral stones achieving the highest rates 1, 2
- Stones 5-7 mm: Pass in approximately 60% of cases 2
- Stones 7-9 mm: Pass in approximately 48% of cases 2
- Stones >10 mm: Pass in only 25% or fewer cases and should be offered medical expulsive therapy or surgical intervention 3, 2
Location-Specific Considerations
Stone location within the urinary tract significantly impacts passage rates:
- Distal ureteral stones: 68-83% passage rate overall, with 89% for stones <5 mm 1
- Mid-ureteral stones: 58-70% passage rate 1
- Proximal ureteral stones: 49-52% passage rate 1
Distal stones are approximately 1.6 times more likely to pass than proximal stones of the same size. 2
Timeline for Spontaneous Passage
Stones that will pass spontaneously typically do so within a predictable timeframe:
- Average passage time: 17-24 days (range 6-29 days) 1, 4
- Stones ≤2 mm: Average 8 days, with 95% passing by 31 days 5
- Stones 2-4 mm: Average 12 days, with 95% passing by 40 days 5
- Stones 4-6 mm: Average 22 days, with 95% passing by 39 days 5
Medical Expulsive Therapy
For stones ≤10 mm in the distal ureter, alpha-adrenergic blockers (tamsulosin, alfuzosin, doxazosin, terazosin, or silodosin) should be offered for approximately 30 days to facilitate stone passage, reduce pain episodes, and decrease unplanned healthcare encounters. 3 This represents a strong recommendation with Grade A evidence from meta-analyses of over 8,000 patients. 3
For mid and proximal ureteral stones ≤10 mm, medical expulsive therapy may be offered but has less robust evidence supporting its efficacy. 3
Gender-Specific Considerations
Female sex is independently associated with a higher likelihood of requiring urologic intervention (OR 3.9,95% CI 1.8-8.7), even after controlling for stone size and location. 6 This suggests that while passage rates are based on stone characteristics, female patients may experience more complications or symptoms requiring intervention despite similar stone parameters.
Clinical Decision-Making Algorithm
For stones ≤5 mm: Offer conservative management with medical expulsive therapy for 30 days, as passage rates exceed 75% 1
For stones 5-10 mm: Offer medical expulsive therapy with close follow-up; consider surgical intervention if no passage by 30-40 days or if complications develop 3, 1
For stones >10 mm: Recommend surgical intervention (ureteroscopy or shock wave lithotripsy) as spontaneous passage is unlikely 3, 2
Contraindications to Conservative Management
Conservative management should be discontinued immediately if any of the following develop:
- Urinary tract infection with obstruction 1
- Refractory pain despite adequate analgesia 1
- Declining renal function 1
- Bilateral obstruction or obstruction in a solitary kidney 6
Important Caveats
Patients with a solitary kidney have a 9-fold increased risk of requiring intervention (OR 9.0,95% CI 1.7-49.0) and should be monitored more closely regardless of stone size. 6
Proximal stone location increases intervention risk 4-fold (OR 4.1,95% CI 1.5-11.7) compared to distal stones. 6
The absence of perinephric fat stranding and tissue rim sign on CT imaging are the strongest predictors of spontaneous passage and should be considered when counseling patients about conservative management. 7